Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about renal cell carcinoma Recent news which mentions renal cell carcinoma Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer February 17, 2022 Tickers ALKS Tags ALKS renal cell carcinoma Market News From Benzinga Bristol Myers, Exelixis Tout Additional Opdivo/Cabometyx Combo Data From Kidney Cancer Trial February 15, 2022 Tickers BMY EXEL Tags EXEL Briefs News From Benzinga Aveo Says Tivozanib Patients Up To 5X More Likely To Experience Long-Term PFS Vs. Nexavar In Kidney Cancer February 15, 2022 Tickers AVEO BAYRY Tags General Benzinga Phase 3 Trial From Benzinga Merck's Keytruda Wins European Approval For Post-Surgery Kidney Cancer January 27, 2022 Tickers MRK Tags MRK General Market News From Benzinga EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer December 17, 2021 Tickers MRK Tags Health Care Benzinga Biotech From Benzinga Bristol Myers Touts 5-Year Kidney Cancer Data For Opdivo-Yervoy Combo Therapy September 16, 2021 Tickers BMY PFE Tags General Briefs PFE From Benzinga Exelixis' Cabometyx Combo Trial Shows Benefit In Kidney Cancer Regardless Of Prior Surgery September 16, 2021 Tickers BMY EXEL PFE Tags EXEL News Health Care From Benzinga Exelixis - Takeda's Cabometyx Scores Approval In Japan For Kidney Cancer August 26, 2021 Tickers BMY EXEL TAK TKPHF Tags BMY renal cell carcinoma Market News From Benzinga Merck's Belzutifan Wins FDA Approval As First Drug For Rare VHL Tumors August 16, 2021 Tickers MRK Tags Biotech Benzinga tumors From Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.